ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer
Artículo
Acceso abierto
Artículo
DOAJ
Abstract Endocrine therapy (ET) resistance in estrogen receptor positive (ER+) advanced breast cancer is often linked to ESR1 mutations, yet responses to oral selective ER degraders vary within mutant subgroups. Through ...
LCC TENDOlNjaWVuY2U~Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access